PHOENIX, Feb. 6, 2023
/PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the
"Company"), (www.senestech.com) the rodent fertility control
experts and inventors of the only EPA registered contraceptive for
male and female rats, ContraPest®, today announced that the
New York State Department of
Environmental Conservation has approved ContraPest for General Use,
removing "Restricted Use Pesticide" (RUP) from the label of
ContraPest. This expands the market for ContraPest dramatically in
New York, as it no longer requires
application by specially licensed pest control companies and
eliminates restrictive handling and paperwork.
In 2018, the EPA removed the RUP label and approved ContraPest
for General Use. However, individual states maintain their own
requirements for General Use classification. New York now becomes the 49th state
to remove the RUP label from ContraPest and joins Washington D.C. and major U.S. Territories
using ContraPest under the General Use label, validating years of
effective and incident-free experience.
"The removal of the RUP label in New
York now allows us to significantly expand our efforts to
introduce ContraPest in New York,"
said Joel Fruendt, SenesTech's CEO.
"The Mayor of New York City has
declared fighting rats as a top priority. As we have shown in other
markets, adding ContraPest to New
York's pest control toolbox can show dramatic reduction in
rats, proving population control is the key to success in the
ongoing battle. We look forward to working with government
agencies, agribusiness, food production facilities, property
managers and other non-PMPs, including do-it-yourselfers, who want
to effectively control their rat populations with ContraPest."
About SenesTech
We are the experts in rat fertility
control. Our passion is to create a healthy environment by better
controlling rat pest populations. We keep an inescapable truth in
mind. Two rats and their descendants can be responsible for the
birth of up to 15,000 pups after a year. We invented ContraPest,
the only U.S. EPA registered contraceptive for male and female
rats. ContraPest fits seamlessly into all integrated pest
management programs, greatly improving the overall goal of
effective rat management. We strive for clean cities, efficient
businesses, and happy households – with a product that was designed
to be effective and sustainable without killing rats. At
SenesTech, we are committed to improving the health of the world by
humanely managing animal populations through fertility control.
For more information visit https://senestech.com/ and
https://contrapeststore.com.
Safe Harbor Statement
This press release contains
"forward-looking statements" within the meaning of federal
securities laws, and we intend that such forward-looking statements
be subject to the safe harbor created thereby. Such forward-looking
statements include, among others, our belief that removing RUP from
the label of ContraPest in the state of New York expands the market for ContraPest
dramatically in New York; our
belief that the removal of the RUP label validates years of
effective and incident-free experience; our belief that the removal
of the RUP label in New York now
allows us to significantly expand our efforts to introduce
ContraPest in New York; our belief
that adding ContraPest to New
York's pest control toolbox can show dramatic reduction in
rats, proving population control is the key to success in the
ongoing battle; and our belief that ContraPest fits seamlessly into
all integrated pest management programs, greatly improving the
overall goal of effective rat management. Forward-looking
statements may describe future expectations, plans, results or
strategies and are often, but not always, made through the use of
words such as "believe," "may," "future," "plan," "will," "should,"
"expect," "anticipate," "eventually," "project," "estimate,"
"continuing," "intend" and similar words or phrases. You are
cautioned that such statements are subject to risks, uncertainties
and other factors that could cause actual results to differ
materially from those reflected by such forward-looking statements.
Such factors include, among others, the impacts and implications of
the COVID-19 pandemic, the successful commercialization of our
products, market acceptance of our products, regulatory approval
and regulation of our products and other factors and risks
identified from time to time in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K for
the fiscal year ended December 31,
2021. All forward-looking statements contained in this press
release speak only as of the date on which they were made and are
based on management's assumptions and estimates as of such date.
Except as required by law, we do not undertake any obligation to
publicly update any forward-looking statements, whether as a result
of the receipt of new information, the occurrence of future events
or otherwise.
CONTACT:
Investors: Robert Blum, Lytham
Partners, LLC, 602-889-9700, senestech@lythampartners.com
Press: Nicole Williams, Chief
Revenue Officer, SenesTech, Inc., 928-779-4143
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/contrapest-approved-for-general-use-in-new-york-state-301739051.html
SOURCE SenesTech, Inc.